🔗 Visit the ClinicalTrials.gov page for NCT01562873
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. | J Biol Chem | 2013 | 1.15 |
| 2 | Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways. | Pharmgenomics Pers Med | 2014 | 1.09 |